US FDA May Change Opioid Labeling To Limit Dispensing By Indication
Executive Summary
Commissioner Gottlieb says FDA is looking to work with provider groups to set dosage based on indication; Patrick Kennedy is calling on CMS to provide reimbursement for opioid addiction treatment.
You may also be interested in...
Opioid Litigation: Court Asks US FDA To Attend Education Session
Judge overseeing multidistrict litigation convenes meeting with senior pharma executives, government plaintiffs and others to learn about supply-chain dynamics and other issues to resolve more than 200 suits.
Opioid Packaging Standards Could Emerge From Dosage Guidelines in Labeling
US FDA wants to work with practitioners to develop suggested prescribing standards, which could then be used to create packaging requirements.
Opioid Packaging Standards Could Emerge From Dosage Guidelines in Labeling
US FDA wants to work with practitioners to develop suggested prescribing standards, which could then be used to create packaging requirements.